Literature DB >> 17556668

The macrophage at the crossroads of insulin resistance and atherosclerosis.

Chien-Ping Liang1, Seongah Han, Takafumi Senokuchi, Alan R Tall.   

Abstract

The macrophage has emerged as an important player in the pathogenesis of both atherosclerosis and insulin resistance. Cross-talk between inflammatory macrophages and adipocytes may be involved in insulin resistance in peripheral tissues. Defective insulin signaling in cells of the arterial wall including macrophages may promote the development of atherosclerosis. Insulin resistant macrophages are more susceptible to endoplasmic reticulum stress and apoptosis in response to various stimuli such as nutrient deprivation, free cholesterol loading, and oxidized LDL. Increased apoptosis of insulin resistant macrophages and impaired phagocytic clearance of apoptotic cells by insulin resistant macrophages in atherosclerotic lesions may lead to enhanced postapoptotic necrosis, larger lipid-rich cores, increased inflammation, and more complex vulnerable plaques.

Entities:  

Mesh:

Year:  2007        PMID: 17556668     DOI: 10.1161/CIRCRESAHA.107.152165

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  51 in total

Review 1.  Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases.

Authors:  Daiju Fukuda; Masanori Aikawa
Journal:  Circ J       Date:  2013-09-12       Impact factor: 2.993

2.  CSF-1 and TPA stimulate independent pathways leading to lysosomal degradation or regulated intramembrane proteolysis of the CSF-1 receptor.

Authors:  Gary Glenn; Peter van der Geer
Journal:  FEBS Lett       Date:  2007-10-29       Impact factor: 4.124

3.  Toll-like receptors stimulate regulated intramembrane proteolysis of the CSF-1 receptor through Erk activation.

Authors:  Gary Glenn; Peter van der Geer
Journal:  FEBS Lett       Date:  2008-02-21       Impact factor: 4.124

4.  Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography.

Authors:  Benjamin D Horne; Heidi T May; Jeffrey L Anderson; Abdallah G Kfoury; Beau M Bailey; Brian S McClure; Dale G Renlund; Donald L Lappé; John F Carlquist; Patrick W Fisher; Robert R Pearson; Tami L Bair; Ted D Adams; Joseph B Muhlestein
Journal:  Am J Cardiol       Date:  2008-07-10       Impact factor: 2.778

5.  High glucose-treated macrophages augment E-selectin expression in endothelial cells.

Authors:  Te-Chuan Chen; Shao-Ju Chien; Hsing-Chun Kuo; Wen-Shih Huang; Jiunn-Ming Sheen; Tseng-Hsi Lin; Chia-Kuang Yen; Mao-Lin Sung; Cheng-Nan Chen
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

6.  Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity.

Authors:  Olga T Hardy; Richard A Perugini; Sarah M Nicoloro; Karen Gallagher-Dorval; Vishwajeet Puri; Juerg Straubhaar; Michael P Czech
Journal:  Surg Obes Relat Dis       Date:  2010-06-01       Impact factor: 4.734

7.  Salicylate inhibits macrophage-secreted factors induced adipocyte inflammation and changes of adipokines in 3T3-L1 adipocytes.

Authors:  Yuan An; Kang Liu; Yuan Zhou; Baolin Liu
Journal:  Inflammation       Date:  2009-10       Impact factor: 4.092

Review 8.  The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression.

Authors:  Ira Tabas; Alan Tall; Domenico Accili
Journal:  Circ Res       Date:  2010-01-08       Impact factor: 17.367

Review 9.  Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging.

Authors:  German Perdomo; H Henry Dong
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

10.  CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes.

Authors:  Takuya Komura; Yoshio Sakai; Masao Honda; Toshinari Takamura; Kouji Matsushima; Shuichi Kaneko
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.